Drug Pipeline

RO7204239 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
1
Phase 3
1
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam…
date change Primary completion moved earlier: 2029-02-27 -> 2026-10-28
2026-06-12 NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam…
date change Completion moved earlier: 2029-02-27 -> 2026-10-28
Active Studies by Phase
Phase 2/3
1
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT05115110 A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam… Spinal Muscular Atrophy (SMA) Active, Not Recruiting
Phase 2
NCT05548556 A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy Facioscapulohumeral Muscular Dystrophy (FSHD) Active, Not Recruiting
NCT06965413 A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and… Obesity Active, Not Recruiting
Phase 1
NCT07137585 A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition… Type 2 Diabetes Mellitus Active, Not Recruiting
Sponsors Running RO7204239 Trials
Disease Areas
Get alerts when RO7204239 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free